Molecular docking has demonstrated that peptides are able to prevent the attachment of COVID-19 to ACE2 (angiotensin-converting enzyme 2) and suppress the entry of COVID-19 into host cells (Souza et al., 2020), albeit the studies are currently limited at the preclinical stage. Here, ACE2 is linked to COVID-19.